Pfizer/Parke-Davis integration
Executive Summary
Co-promotion of products (other than Lipitor) by the Pfizer and Parke-Davis sales forces will begin by the end of the year, Pfizer's Katen reported. "At this moment we are cross-training our field organizations." The co-promotions "will be extensive, especially in CNS and cardiovascular." Pfizer has about 8,000 sales reps following the Warner-Lambert merger